Clinical Trials Insight: 700030181
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2010
At a glance
- Drugs BGC 201259 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors BTG
- 02 Apr 2008 Status change from planning to completed, according to a BTG media release.
- 30 Jan 2008 New trial record.